As highlighted in a recently published article in Labiotech.eu, The Novo Nordisk Foundation has awarded a grant of $200 million to establish the first full-scale quantum computer for the development of new medicines
By applying next-generation quantum computing to the life sciences, the Novo Nordisk Foundation and its partners have the ambition to deliver revolutionary and applicable new insights that will transform the understanding of crucial scientific problems that pose a huge unmet medical and environmental need.
“Everyone will eventually benefit from the new opportunities this Programme is creating. This includes areas such as the green transition, cybersecurity and the development of new medicines. The grant ensures that the University of Copenhagen will continue to be among the global leaders in quantum research. With its size, ambition and interdisciplinary collaboration in Denmark and internationally, the Quantum Computing Programme will provide researchers with the opportunity to boost the development of quantum technology. Many thanks to the Novo Nordisk Foundation for contributing wholeheartedly to this research field.” said Henrik C. Wegener, Rector of the University of Copenhagen
The Novo Nordisk Foundation Quantum Computing Programme launched in collaboration with MVA-founding father, University of Copenhagen, includes researchers in quantum computing from Denmark, Canada, The Netherlands and the U.S.